iBio (IBIO) Liabilities from Discontinued Operations (2022 - 2024)

iBio (IBIO) has disclosed Liabilities from Discontinued Operations for 3 consecutive years, with 1933000.0 as the latest value for Q1 2024.

  • Quarterly Liabilities from Discontinued Operations fell 0.57% to 1933000.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was 1933000.0 through Mar 2024, down 0.57% year-over-year, with the annual reading at 1941000.0 for FY2023, 1.52% down from the prior year.
  • Liabilities from Discontinued Operations for Q1 2024 was 1933000.0 at iBio, roughly flat from 1936000.0 in the prior quarter.
  • The five-year high for Liabilities from Discontinued Operations was 1971000.0 in Q2 2022, with the low at 1933000.0 in Q1 2024.
  • Average Liabilities from Discontinued Operations over 3 years is 1944428.57, with a median of 1941000.0 recorded in 2023.
  • Peak annual rise in Liabilities from Discontinued Operations hit 0.56% in 2023, while the deepest fall reached 1.52% in 2023.
  • Over 3 years, Liabilities from Discontinued Operations stood at 1947000.0 in 2022, then fell by 0.56% to 1936000.0 in 2023, then fell by 0.15% to 1933000.0 in 2024.
  • According to Business Quant data, Liabilities from Discontinued Operations over the past three periods came in at 1933000.0, 1936000.0, and 1939000.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.